Body mass index, C-reactive protein, and pancreatic cancer: A Mendelian randomization analysis to investigate causal pathways

Zhenqi Li,Liquan Jin,Lu Xia,Xiangzhi Li,Yunfei Guan,Hongyang He
DOI: https://doi.org/10.3389/fonc.2023.1042567
IF: 4.7
2023-02-03
Frontiers in Oncology
Abstract:Aim: To explore whether C-reactive protein (CRP) mediates the risk of body mass index (BMI) in pancreatic cancer (PC) and calculate the mediate proportion of CRP in this possible mechanism. Methods: Based on two-sample Mendelian randomization (TSMR), a two-step Mendelian randomization (TM) model was conducted to determine whether CRP was a mediator of the causal relationship between BMI and PC. The multivariable Mendelian randomization (MVMR) study was designed for mediating analysis and to calculate the mediating proportion mediated by CRP. Results: BMI has a positive causal relationship with PC (n = 393 SNPs, OR = 1.484, 95% CI: 1.021–2.157, p< 0.05). BMI has a positive causal relationship with CRP (n = 179 SNPs, OR = 1.393, 95% CI: 1.320–1.469, p< 0.05). CRP has a positive causal relationship with PC (n = 54 SNPs, OR = 1.348, 95% CI: 1.004–1.809, p < 0.05). After adjusting CRP, BMI has no causal relationship with PC (n = 334 SNPs, OR = 1.341, 95% CI: 0.884–2.037, p< 0.05). After adjusting BMI, there was still a positive causal relationship between CRP and PC (n = 334 SNPs, OR = 1.441, 95% CI: 1.064–1.950, p< 0.05). The mediating effect of CRP was 29%. Conclusions: In clinical practice, while actively advocating for weight loss among obese patients, we should focus on chronic inflammation levels in obese patients as well. In addition, anti-inflammatory dietary patterns and appropriate physical activity are important in preventing PC.
oncology
What problem does this paper attempt to address?
This paper attempts to explore whether C - reactive protein (CRP) plays an intermediary role in the risk relationship between body mass index (BMI) and pancreatic cancer (PC), and calculate the proportion of mediation of CRP in this possible mechanism. Specifically, the study aims to determine whether CRP is an intermediary factor in the causal relationship between BMI and PC through two - sample Mendelian randomization (TSMR) analysis. The study uses the multivariable Mendelian randomization (MVMR) method for mediation analysis and calculates the proportion of mediation of CRP. ### Research Background - **Pancreatic cancer** (especially pancreatic ductal adenocarcinoma PDAC) is one of the most deadly solid malignancies, and its incidence and mortality are increasing year by year. - **Obesity** is associated with an increased risk of pancreatic cancer. One of the hallmarks of obesity is adipose tissue inflammation, which can promote cancer growth by secreting pro - inflammatory cytokines. - **Systemic low - grade inflammation** may be a potential intermediary factor in the relationship between obesity and pancreatic cancer, and CRP is a common marker of systemic inflammation. ### Research Methods - **Data Sources**: Genetic variation data related to BMI were obtained from the UK Biobank, pancreatic cancer data were obtained from the Finnish biobank, and CRP data were obtained from the International HapMap Project. - **Mendelian Randomization Analysis**: A two - step Mendelian randomization (TM) model was used. First, the relationships between BMI and CRP or PC were determined, and then the relationship between CRP and PC was determined. - **Sensitivity Analysis**: Multiple methods were used to evaluate heterogeneity and horizontal pleiotropy to ensure the robustness of the results. ### Main Results - **BMI and Pancreatic Cancer**: There is a positive causal relationship between BMI and pancreatic cancer (n = 393 SNPs, OR = 1.484, 95% CI: 1.021 – 2.157, p < 0.05). - **BMI and CRP**: There is a positive causal relationship between BMI and CRP (n = 179 SNPs, OR = 1.393, 95% CI: 1.320 – 1.469, p < 0.05). - **CRP and Pancreatic Cancer**: There is a positive causal relationship between CRP and pancreatic cancer (n = 54 SNPs, OR = 1.348, 95% CI: 1.004 – 1.809, p < 0.05). - **After Adjusting for CRP**: After adjusting for CRP, there is no causal relationship between BMI and pancreatic cancer (n = 334 SNPs, OR = 1.341, 95% CI: 0.884 – 2.037, p > 0.05). - **After Adjusting for BMI**: After adjusting for BMI, there is still a positive causal relationship between CRP and pancreatic cancer (n = 334 SNPs, OR = 1.441, 95% CI: 1.064 – 1.950, p < 0.05). - **Mediation Effect**: The mediation effect of CRP is 29%. ### Conclusion In clinical practice, in addition to actively advocating weight loss for obese patients, attention should also be paid to the level of chronic inflammation in obese patients. In addition, anti - inflammatory diet patterns and appropriate physical activities are very important for the prevention of pancreatic cancer.